Reuters logo
BRIEF-Glenmark Pharma gets ANDA approval for nebivolol tablets
May 29, 2017 / 3:33 AM / 7 months ago

BRIEF-Glenmark Pharma gets ANDA approval for nebivolol tablets

May 29 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says Glenmark Pharmaceuticals receives ANDA approval for nebivolol tablets, 2.5 mg, 5 mg, 10 mg and 20 mg

* Co may be eligible for 180 days of generic drug exclusivity for nebivolol tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below